Last reviewed · How we verify
NCT06282562: FeelFit
FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients
NA trial testing High-Intensity Interval Training (HIIT) in Brain Tumor, Primary in 36 participants. Currently enrolling.
15 August 2026
Quick facts
| Lead sponsor | Amsterdam UMC, location VUmc |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 1 January 2024 |
| Primary completion | 15 August 2026 |
| Estimated completion | 15 August 2026 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- High-Intensity Interval Training (HIIT)
Conditions studied
- Brain Tumor, Primary — all drugs for Brain Tumor, Primary →
- Exercise — all drugs for Exercise →
Sponsor
Amsterdam UMC, location VUmc — full company profile →
Who can join
18 and older, any sex, with Brain Tumor, Primary or Exercise. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The FeelFit study aims to assess the effectiveness of High-Intensity Interval Training (HIIT) in improving self-reported physical fitness in adult brain tumor patients during periods of stable disease, as compared to a waiting-list control group. Furthermore, several secondary and exploratory outcomes will be evaluated. The study is part of the GRIP (GuaRding quality survivorshiP) project, which aims to improve quality of life in brain tumor patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06282562
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High-Intensity Interval Training (HIIT)
Trials testing the same drug.
- NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
- NCT07319611 — Investigation of the Effects of High-Intensity Interval Exercise and Moderate-Intensity Continuous Exercise on Limb Volu · NA · not yet recruiting
- NCT07248709 — Comparison of High-Intensity Interval Training and Moderate-Intensity Continuous Training in Mild Cognitive Impairment · NA · recruiting
- NCT07400432 — Acute Effects of Moderate-Intensity Continuous Exercise Versus HIIT on Cognitive Performance and Psychophysiological Res · NA · enrolling by invitation
- NCT07390721 — Diaphragmatic Kinesio Taping With HIIT in Trained Individuals · NA · recruiting
Other recruiting trials for Brain Tumor, Primary
Currently open trials in the same condition.
- NCT06185686 — Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients · recruiting
- NCT05831631 — Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors · recruiting
- NCT04427384 — Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) · recruiting
- NCT05775458 — Glutamate Excitotoxicity and Its Role in Glioblastoma Biology · recruiting
- NCT05254197 — SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON) · recruiting
Other Amsterdam UMC, location VUmc trials
Trials by the same sponsor.
- NCT07470697 — Deep Relaxation Using Virtual Reality Intervention Before Surgery for Healthcare Professionals Working in the Operating · NA · not yet recruiting
- NCT07278206 — Brain Stimulation in Long COVID · NA · recruiting
- NCT07155681 — Evaluating Healthcare Professionals' Satisfaction and Stress Mitigation Using Virtual Reality Intervention in Surgical W · NA · not yet recruiting
- NCT06416345 — Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care · NA · recruiting
- NCT06658522 — Right Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label Phase 4 Study to Evaluate the Effec · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06282562 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Amsterdam UMC, location VUmc
- Last refreshed: 6 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06282562.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing